Montag eröffnet Genomic Solutions (GNSL) die Nasdaq!!! - 500 Beiträge pro Seite
eröffnet am 08.07.00 10:00:22 von
neuester Beitrag 09.07.00 11:36:18 von
neuester Beitrag 09.07.00 11:36:18 von
Beiträge: 7
ID: 178.868
ID: 178.868
Aufrufe heute: 0
Gesamt: 717
Gesamt: 717
Aktive User: 0
Top-Diskussionen
Titel | letzter Beitrag | Aufrufe |
---|---|---|
heute 00:03 | 387 | |
gestern 20:29 | 348 | |
08.05.24, 11:56 | 340 | |
gestern 23:30 | 246 | |
heute 00:34 | 244 | |
heute 01:24 | 195 | |
heute 00:19 | 168 | |
heute 00:27 | 151 |
Meistdiskutierte Wertpapiere
Platz | vorher | Wertpapier | Kurs | Perf. % | Anzahl | ||
---|---|---|---|---|---|---|---|
1. | 1. | 18.704,42 | -0,18 | 186 | |||
2. | 4. | 6,5320 | -2,74 | 81 | |||
3. | 14. | 22,210 | -19,73 | 73 | |||
4. | 18. | 31,51 | +6,45 | 69 | |||
5. | 6. | 10,700 | +1,71 | 66 | |||
6. | 10. | 16,750 | +4,69 | 47 | |||
7. | 5. | 177,46 | +1,50 | 47 | |||
8. | 3. | 4,4000 | -5,17 | 42 |
Am Montag wird der Megaknaller Genomic Solutions die Nasdaq in einer feierlichen Zeremonie eröffnen. Dann werden bestimmt noch ein paar Leute mehr auf diese geniale Aktie aufmerksam. Der Kursverlauf spricht für sich!!!!
Kann dem nur zustimmen - Freitag über 20% +++
Warmupper
Warmupper
Was denn für ´ne feierliche Zeremonie?
Danke!
K.H.
Danke!
K.H.
!
Dieser Beitrag wurde vom System automatisch gesperrt. Bei Fragen wenden Sie sich bitte an feedback@wallstreet-online.de
Für Karl-Heinz:
News Advisory: Genomic Solutions to Open NASDAQ on July 10, 2000
Monday, July 10, 2000
9:30 a.m.
NASDAQ MarketSite
4 Times Square
43rd & Broadway
New York, NY 10036
Genomic Solutions Inc., (Nasdaq: GNSL), a supplier of instruments and systems (tools) for large-scale genomic and proteomic research, will open NASDAQ during a MarketSite ceremony to recognize its successful initial public offering that commenced May 5, 2000.
The event is particularly timely in light of recent announcements that mapping of the Human Genome has been completed. But mapping is only the first step in genomic research; genes and the proteins they define require close examination using automated, high-throughput systems.
This genomic information also requires substantial interpretation before it becomes useful for discovering new drugs. GNSL supplies tools that help make such examination, interpretation and discovery possible.
Genomic Solutions designs, develops, manufactures, markets and sells instruments, software, consumables and services used to determine the activity level of genes and to isolate, identify and characterize proteins. The company`s products and systems enable researchers to perform complex, high volume experiments at a lower cost and in less time than traditional techniques. As a result, Genomic Solutions products and systems facilitate more rapid and less expensive drug discovery.
Genomic Solutions markets products through its corporate headquarters in Ann Arbor, Michigan USA, as well as offices in the United Kingdom and Japan. Remaining worldwide distribution is provided by PerkinElmer Life Sciences through a strategic alliance with Genomic Solutions. The two companies also cooperate to sell co-branded products and collaborate to leverage their intellectual property and technologies.
For more information or to schedule an interview with a Genomic Solutions officer on July 10 or 11 in New York, contact Kathleen Murphy, KATCOM Marketing Communications. Preferred contact is by e-mail: katcom@compuserve.com, or by phone: 219.287.2540.
--------------------------------------------------------------------------------
Home | Contact GSI
Products & Services | Investor Relations | Training & Tech Support | Media & News
News Advisory: Genomic Solutions to Open NASDAQ on July 10, 2000
Monday, July 10, 2000
9:30 a.m.
NASDAQ MarketSite
4 Times Square
43rd & Broadway
New York, NY 10036
Genomic Solutions Inc., (Nasdaq: GNSL), a supplier of instruments and systems (tools) for large-scale genomic and proteomic research, will open NASDAQ during a MarketSite ceremony to recognize its successful initial public offering that commenced May 5, 2000.
The event is particularly timely in light of recent announcements that mapping of the Human Genome has been completed. But mapping is only the first step in genomic research; genes and the proteins they define require close examination using automated, high-throughput systems.
This genomic information also requires substantial interpretation before it becomes useful for discovering new drugs. GNSL supplies tools that help make such examination, interpretation and discovery possible.
Genomic Solutions designs, develops, manufactures, markets and sells instruments, software, consumables and services used to determine the activity level of genes and to isolate, identify and characterize proteins. The company`s products and systems enable researchers to perform complex, high volume experiments at a lower cost and in less time than traditional techniques. As a result, Genomic Solutions products and systems facilitate more rapid and less expensive drug discovery.
Genomic Solutions markets products through its corporate headquarters in Ann Arbor, Michigan USA, as well as offices in the United Kingdom and Japan. Remaining worldwide distribution is provided by PerkinElmer Life Sciences through a strategic alliance with Genomic Solutions. The two companies also cooperate to sell co-branded products and collaborate to leverage their intellectual property and technologies.
For more information or to schedule an interview with a Genomic Solutions officer on July 10 or 11 in New York, contact Kathleen Murphy, KATCOM Marketing Communications. Preferred contact is by e-mail: katcom@compuserve.com, or by phone: 219.287.2540.
--------------------------------------------------------------------------------
Home | Contact GSI
Products & Services | Investor Relations | Training & Tech Support | Media & News
Damit wir noch viele "Genomic Solutions" finden, hier eine geniale Seite: www.smallcapcenter.com
@Badagry,
Danke - aber ich konnte mir nicht vorstellen, wie man eine Eröffnung an einer Computerbörse inszenieren will!
so long,
K.H.
Danke - aber ich konnte mir nicht vorstellen, wie man eine Eröffnung an einer Computerbörse inszenieren will!
so long,
K.H.
Beitrag zu dieser Diskussion schreiben
Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie eine neue Diskussion.
Meistdiskutiert
Wertpapier | Beiträge | |
---|---|---|
187 | ||
79 | ||
74 | ||
70 | ||
65 | ||
48 | ||
44 | ||
41 | ||
39 | ||
39 |
Wertpapier | Beiträge | |
---|---|---|
31 | ||
29 | ||
27 | ||
26 | ||
23 | ||
22 | ||
21 | ||
18 | ||
17 | ||
17 |